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Abstract
Background: Diabetes is a chronic medical condition and adherence to medication in adults with diabetes is
important. Identifying predictors to medication adherence in adults with diabetes would help identify vulnerable
patients who are likely to benefit by improving their adherence levels.
Methods: We conducted a cross-sectional study at the Dubai Police Health Centre between February 2015 and
November 2015. Questionnaires were used to collect socio-demographic, clinical and disease related variables and
the primary measure of outcome was adherence levels as measured by the Morisky Medication Adherence Scale
(MMAS-8©). Multivariate logistic regression was carried out to identify predictors to adherence.
Results: Four hundred and forty six patients were interviewed. Mean age 61 year +/− 11. 48.4 % were male. The
mean time since diagnosis of diabetes was 3.2 years (Range 1–15 years). Two hundred and eighty eight (64.6 %)
patients were considered non-adherent (MMAS-8© adherence score < 6) while 118 (26.5 %) had moderate
adherence (MMAS-8© adherence score 6 = <8) and 40 (9.0 %) high adherence (MMAS-8© adherence scores <8) to
their medication respectively. The strongest predictor for adherence as predicted by the multi-logistic regression
model was the patient’s level of education. A technical diploma certificate as compared to a primary school level of
education was the strongest predictor of adherence (OR = 66.1 CI: 6.93 to 630.43); p < 0.001). The patient’s age was
also a predictor of adherence with older patients reporting higher levels of adherence (OR = 1.113 (CI: 1.045 to 1.
185; p = 0.001 for every year increase in age). The duration of diabetes was also a predictor of adherence (OR = 1.
830 (CI: 1.270 to 2.636; p = 0.001 for every year increase in the duration of diabetes). Other predictors to medication
adherence include Insulin use, ethnicity and certain cultural behaviours.
Conclusion: A number of important predictors to medication adherence in diabetics were identified in this study.
Such predictors could help develop policies for improving adherence in diabetics.
Keywords: Diabetes, Adherence, Medication
Background
Diabetes mellitus is a chronic metabolic disease affecting
approximately 341 million to 371 million people world-
wide [1, 2]. Furthermore, it is estimated that one third of
those affected (approximately 122.5 million) are not
aware that they have the condition [3].
The oil boom has led to a massive increase in the
GDP and disposable income of the people of the United
Arab Emirates (UAE). The UAE was ranked as the 19th
highest income countries of the world in 2012 (Inter-
national Monetary Fund) and is categorized as a high in-
come country according to the (World bank, 2012). This
has led to a more affluent lifestyle, and from health point
an increase in total calorie intake per person together
with a decrease in calorie expenditure. This has led to a
nationwide obesity pandemic with the rates of obesity
climbing to record highs and standing at about 68 % of
the population according to one estimate from 2007.
The United Arab Emirates (UAE) is now being listed
as the country with the 11th highest prevalence of
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diabetes globally (primarily type-2) [4]. Furthermore,
metabolic control of diabetes is reportedly poor, leading
to an increased risk of associated complications [5].
Almost 70 % of Emirati nationals are reported to be
overweight or obese [6], and one third of Emirati chil-
dren are also now obese [7]; these figures are two to
three times those of international standards [8], thus, it
is not surprising that the prevalence of type-2 diabetes
has escalated.
Medication non-adherence is of increasing concern for
healthcare providers despite the known benefits of mod-
ern treatment regimens, with prevalence reported in one
study to be in excess of 50 % of diabetic patients. The
consequences of non-adherence include not only health-
related consequences (i.e. failure of treatment, re-
hospitalisation, death), but also financial consequences
as the cost of emergency medical interventions as a con-
sequence of non-adherence outweigh the combined cost
of an adhered-to medication regimen [9]. The WHO has
identified non-adherence as a multifactorial problem
caused by the interplay of factors from any of the follow-
ing 5 areas: 1) the patient, 2) the condition, 3) the type
of therapy prescribed, 4) socioeconomic factors, and 5)
health system related factors [10]. Several studies have
been carried out looking at medication adherence in
diabetic patients around the world; however no studies
have been performed in the U.A.E [11–13].
Methods
Study design
This was a cross-sectional study looking at predictors to
medication adherence among diabetics as measured by
the Morisky Medication adherence scale (MMAS-8©).
The predictors were identified from variables collected
via questionnaires and then analysed using statistical
software.
Study setting
The study took place at the Dubai Police Health Services
Clinic between February 2015 and November 2015. This
centre provides primary care and speciality care for all
Dubai Police employees and members of their families
and had over 200,000 clinic visits in 2014 alone. The
patients were identified from the diabetes clinics and
were approached at the time of their routine scheduled
diabetes checks. The patients were given a patient infor-
mation sheet and the study was explained to them. The
patients were then asked to sign a consent sheet and
subsequently asked to fill in a questionnaire and attend
a blood test. The research topic was granted an ethical
clearance through the Human Research Ethics Commit-
tee at Griffith University GU Ref No: PBH/11/14/HREC
and confirmed with the Dubai Police Research Ethics
standards.
Recruitment procedure (inclusion and exclusion criteria)
All patients had to be type 2 diabetics on at least one
anti-diabetic medication following a diabetes diagnosis
of one year or more. Male and female patients between
the age of 18 and 80 years were eligible for the study.
The following exclusions applied: cognitive impairment
(if previously included in medical history),, pregnant or
breastfeeding women, non-residents and patients who
did not comprehend either the English or Arabic
language.
The investigators identified and screened potential
participants in the following manner: all patients present
in the waiting area of the diabetic clinic were screened
by reviewing their medical charts to ensure that all
inclusion criteria were met. They were then asked if they
are willing to talk to the investigator. If the person
agreed an informed consent was then read and explained
by the investigators. Once verbal consent was obtained,
the inclusion and exclusion criteria were checked again.
The Tablet based questionnaires required for the study
were explained to the patient and a qualified phlebotom-
ist obtained the blood sample. All participants com-
pleted the questionnaires in a private clinic room.
Data collection techniques
Data was collected primarily via questionnaires. These
questionnaires were written using the Android Database
software package (MEMENTO). The questionnaires
were then handed out in an electronic form using an
Android tablet. The tablets were purchased for the
purpose of this research and were solely used for this
purpose. These tablets were secured with an encrypted
password and were locked in the research office when
not in use. The tablets and questionnaires were super-
vised by one of the research investigators at the time of
interview to ensure the correct handling of the question-
naire and to troubleshoot any problems if they would
arise. The questionnaire forms were based on a number
of field styles including free text, date, single best answer
and multi-check selections. The database software
collated the results into an excel sheet which was later
exported to a computer for further data analysis.
Data variables
The data collated via the questionnaires included the fol-
lowing variables: age, gender, ethnicity, marital status,
highest level of education attained, working conditions,
transport availability, smoking status, diabetes duration,
cultural factors (dress wear, behaviors in Ramadan, per-
ception towards obesity), number of antidiabetic medica-
tion, insulin therapy, the Depression, Anxiety and Stress
scale (DASS-21) and International Physical Activity
Questionnaire (IPAQ) score. The Morisky Medication
Adherence Scale −8 (MMAS-8) score was used to
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measure the outcome of adherence to medication.
MMAS-8. Glycated hemoglobin (HBA1c (%)) was used
to check the validity of the MMAS-8 score in this cohort
as a measure of adherence to medication among the
study participants.
Morisky medication adherence scale
The Morisky Medication Adherence Scale (MMAS) was
designed to determine adherence behaviours [14]. For
this study the 8-item model of this scale was used;
patients were asked 8 questions designed to determine
which factors affect how well they adhered to their
medication regimen Table 1.
Patients are required to answer the questions with
either a ‘yes’ or a ‘no’, with the final question taking the
form of a typical five-point Likert item. Positive answers
(i.e. yes) are scored a 1 and negative answers (i.e. no) are
scored a 0. From these responses a final score was calcu-
lated with three possible outcomes; a score of >2 corre-
sponded to low medication adherence, a score of 1 or 2
corresponded to medium medical adherence, and a
score of 0 corresponded to high medical adherence. The
MMAS is a popular, easy and economical method of
data collection, facilitating the collection of a large
amount of data in a short period of time [15].
Depression, anxiety and stress scale
The Depression, Anxiety and Stress scale (DASS) was
developed by researchers in New South Wales, Australia.
Its purpose is to measure the patient’s response to a
series of questions regarding the frequency and severity
of recent negative, emotional experiences. In total, there
are 42 items (although the DASS is also available in a
condensed 21 item form the DASS 21) to which patients
are required to answer via the means of a four-point
Likert scale. Each category (depression, anxiety and
stress) is examined by 14 items each, further broken
down into subcategories to examine specific aspects of
each condition. The score (sum or mean) of individual
scales (depression, anxiety OR stress), or the total scale
(depression, anxiety AND stress) can be used to provide
an indication of the severity of the patient’s condition.
As depression, anxiety and stress are intrinsically dimen-
sional, assigning a ‘cut-off ’ or ‘clinical norm’ against
which to compare patients, is arbitrary. However, the
outcome of the DASS has been reported as normal,
mild, moderate, severe, or extremely severe [16], The
DASS has been fully validated against a number of exist-
ing measures of depression, anxiety and stress [17–19].
The DASS-21 score was utilized in this study.
International physical activity questionnaire
The IPAQ score has been extensively validated and cul-
turally adopted and translated into different languages
including Arabic. The questionnaires used for employed
the “7-day recall IPAQ self-administered version”. The
Arabic translation for these items has been published
online and has been used in different research in Arabic
speaking countries [20, 21]. The Arabic translation for
these items has been published online and has been used
in different research in Arabic speaking countries. The
IPAQ score measured would be a useful way of measur-
ing activity in the study population in a standardized
method which would increase the reliability of the data
collected and, in the future, make it easier to compare
findings from this study with others. The IPAQ score
protocol used to analyse the questionnaire has been
published online by the official IPAQ group on the
following webpage (www.IPAQ.ki.se) and is summarized
as follows:
Category 1: Low This is the lowest level of physical
activity. Those individuals who do not meet criteria
for categories 2 or 3 are considered low/inactive.
Table 1 The 8 questions asked to determine medication
adherence based on the Morisky Medication Adherence Scale
Item Answer Number %
Do you sometimes forget to take
your diabetes pills?
Yes 176 39.5 %
No 270 60.5 %
People sometimes miss taking their
medications for reasons other than
forgetting. Thinking over the past
two weeks, were there any days
when you did not take your Diabetes
medicine?
Yes 169 37.9 %
No 277 62.1 %
Have you ever cut back or stopped
taking your medication without
telling your doctor, because you
felt worse when you took it?
Yes 149 33.4 %
No 297 66.6 %
When you travel or leave home, do
you sometimes forget to bring along
your Diabetes medication?
Yes 220 49.3 %
No 226 50.7 %
Did you take your Diabetes medicine
yesterday?
No 388 87.0 %
Yes 58 13.0 %
When you feel like your diabetes is
under control, do you sometimes
stop taking your medicine?
Yes 261 58.5 %
No 185 41.5 %
Taking medication everyday is a real
inconvenience for some people. Do
you ever feel hassled about sticking
to your diabetes treatment plan?
Yes 204 45.7 %
No 242 54.3 %
How often do you have difficulty
remembering to take all of your
medicine?
Never/rarely 50 11.2 %
Once in a
while
69 15.5 %
Sometimes 96 21.5 %
Usually 101 22.6 %
All the time 130 29.1 %
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Category 2: Moderate Any one of the following 3
criteria:
• 3 or more days of vigorous activity of at least 20 min
per day OR • 5 or more days of moderate-intensity activ-
ity or walking of at least 30 min per day OR • 5 or more
days of any combination of walking, moderate-intensity
or vigorous intensity activities achieving a minimum of
at least 600 MET-min/week. Category 3: High Any one
of the following 2 criteria: • Vigorous-intensity activity
on at least 3 days and accumulating at least 1500 MET-
minutes/week OR • 7 or more days of any combination
of walking, moderate-intensity or vigorous intensity
activities achieving a minimum of at least 3000 MET-
minutes/week.
Results
The Baseline characteristics are shown in Table 2. Two
hundred and eighty eight (64.6 %) patients were consid-
ered non-adherent (MMAS-8© adherence score < 6)
while 118 (26.5 %) and 40 (9.0 %) had medium adher-
ence (MMAS-8© adherence score 6 to <8) and high
adherence (MMAS-8© adherence scores =8) to their
medication respectively (Fig. 1).
More than a third (39.5 %) of the participants reported
that sometimes they forgot to take their anti-diabetic
medications; 37.9 % reported that they did not take their
medications on at least one occasion in the two weeks
before the interview; 33.4 % reported that they discon-
tinued taking their medications without telling their
doctor when they felt worse upon taking their medica-
tions; 49.3 % reported that they sometimes forgot to take
their medications with them when they travelled or left
home; 13.0 % reported taking all their medications on
the day before the interview; 58.5 % reported that they
stopped taking their medicines when they felt like their
diabetic symptoms were under control; 45.7 % reported
feeling hassled by their treatment plans; and finally
88.8 % reported that they had difficulty remembering to
take all their medicines at least once in awhile (Table 1).
Reliability, internal consistency and validity of MMAS-8
The Cronbach’s alpha test was calculated for the 8-item
MMAS-8 and this was reliable at 0.736 Omission of any
of the 8-items of the MMAS-8 questionnaire resulted in
a lower Cronbach’s alpha. The validity of MMAS-8
adherence score was assessed by testing the ability of the
score to distinguish between groups of individuals that
differ from each other according to the HbA1c. There
was a significant difference in the Mean HbA1c levels
among the three adherence groups. Mean HbA1c was
9.24, 7.33 and 6.60 % in the low, medium and high
adherence groups respectively (p < 0.05).
Patient, socioeconomic and health care system factors
Age, gender and ethnicity
There was a statistically significant difference in the
mean age of patients who reported low adherence levels
(MMAS-8 < 6) compared to those who reported
Medium (MMAS-8 = 6 to 7) or High adherence levels
(MMAS-8 = 8) (59 years versus 64 years, 69 years
respectively p < 0.05).
Females tended to report high adherence levels
compared to males (13.5 % vs 4.2 %, p = 0.001). Ad-
herence levels also differed significantly between dif-
ferent ethnic groups with the lowest adherence levels
reported by Emirati patients (81.6 %) followed by
Arab Non-Emirati (47.1 %) and Asians (15.4 %) (Pearson
Chi-Square p < 0.001) (Table 3).
Marital status, living arrangements, level of education,
working status and transport availability
Married patients represented the majority of the cohort
group with 66 % (n = 254), 26.5 % (n = 102), and 7.5 %
(n = 29) of the patients married in the low, medium and
high adherence groups respectively. Seventy-One per
cent (n = 5) of widowed patients reported high levels of
adherence (MMAS-8 = 8) compared to 28.6 % (n = 2)
who reported medium or low levels of adherence. This
was a statistically significant difference (p < 0.001),
however of note is the small number of overall widowed
patients. Patients who reported high adherence levels
(MMAS-8 = 8) were more likely to have a higher educa-
tion level compared to those who reported medium or
Table 2 Self-reported medication adherence behaviour of study
participants as determined by the Morisky 8-Item Medication
Adherence Scale (MMAS-8©)
Age (mean +/− std) 61 +/− 11
Gender Female 51.6 % (230)
Male 48.4 %(216)
Ethnicity Arab Emarati 56.1 % (250)
Arab Non-Emarati 38.1 % (170)
Asian 5.8 % (26)
HbA1c baseline (mean +/− std) 8.50 +/− 0.07
SBP at baseline (mean +/− std) 133 +/− 26
DBP at baseline (mean +/− std) 72 +/− 21
HDL at baseline (mean +/− std) 54 +/− 11
LDL at baseline (mean +/− std) 129 +/− 37
TGL at baseline (mean +/− std) 212 +/− 42
Anti-Diabetic therapy Monotherapy 29.4 % (131)
Combination 70.6 % (315)
Insulin use Yes 50.2 % (224)
No 49.8 % (222)
Prescence of chronic conditions Yes 54.0 % (224)
No 46.0 % (205)
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low adherence rates; 62.5 % had a university degree vs
21.2 and 15.6 % (p < 0.005). There were no significant
differences in the living arrangements, transportation
availability or working status between the different
adherence groups.
IPAQ
Two-hundred and sixty eight patients reported low
physical activity as indicated by their IPAQ scores.
Low physical activity was reported more in the group
of low adherence as compared to medium and high
adherence patients (75.7 % vs 22.4 % vs 1.9 % p < 0.001).
Conversely, patients with higher physical activity
scores reported higher adherence levels.
DASS-21
The DASS-21 score was calculated for each of the
following categories; depression, anxiety and stress. Low
Fig. 1 Reported adherence rates in total study population
Table 3 Adherence levels differed significantly with the patients gender and ethnic group
Adherence level
Low adherence (MMAS-8 < 6) Medium adherence (MMAS-8 = 6 to <8) High adherence (MMAS-8 = 8)
Row % N Row % n Row % n
Gender Female 57.8 % 133a 28.7 % 66a 13.5 % 31b
Male 71.8 % 155a 24.1 % 52a 4.2 % 9b
Ethnicity Arab Emarati 81.6 % 204a 15.6 % 39b 2.8 % 7b
Arab Non-Emarati 47.1 % 80a 38.2 % 65b 14.7 % 25b
Asian 15.4 % 4a 53.8 % 14b 30.8 % 8b
Note: Values in the same row and sub-table not sharing the same subscript are significantly different at p < .05 in the two-sided test of equality for column proportions.
Cells with no subscript are not included in the test
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adherents to medication were less likely to report a
normal depression score compared to those who were
moderately and highly adherent to their medication
(39.6 % vs 49.2 % vs 70 % respectively, p = 0.004). Low
adherents to medication were also more likely to report
severe levels of anxiety scores compared to those who
were moderately and highly adherent to their medication
(29.2 % vs 16.9 % vs 10.0 % respectively, p < 0.001). Low
adherents to medication were also more likely to report
severe stress scores compared to those who were moder-
ately and highly adherent to their medication (20.1 % vs
8.5 % vs 5.0 % respectively, p = 0.004).
Cultural factors
Statistical analysis of the data collected has revealed
interesting and novel findings when it comes to the
influence of cultural factors towards the attitude of dia-
betic patients to their adherence to medication (Table 4).
Low adherents to medication were more likely to wear
loose traditional clothes (Dishdasha, Kandoura, Abaya
and Jelbab) compared to those who were moderately
and highly adherent to their medication (75.7 % vs
19.5 % vs 57.5 % respectively, p < 0.001). Low adherents
to medication were also less likely to alter their medica-
tion under the guidance of their doctor during fasting in
the Holy month of Ramadan compared to those who
were moderately and highly adherent to their medication
(92 % vs 53.4 % vs 32.5 % respectively, p < 0.001). Low
adherents to medication were also less likely to notice
changes in their weight compared to those who were
moderately and highly adherent to their medication
(85.1 % vs 62.7 % vs 30 % respectively, p < 0.001). Low
adherents to medication were more likely to gain weight
during the fasting month of Ramadan compared to
those who were moderately and highly adherent to
their medication (83.7 % vs 48.3 % vs 32.5 % respect-
ively, p < 0.001). Low adherents to medication were
more likely to find hot weather during summer a chal-
lenge to exercise compared to those who were moder-
ately and highly adherent to their medication (88.2 % vs
39.8 % vs 47.5 % respectively, p < 0.001).
Condition and therapy variables
Low adherents to medication were less likely to be on
combination anti-diabetic therapy compared to those
who were moderately and highly adherent to their medi-
cation (68.1 % vs 89.8 %, p < 0.001). Low adherents to
medication were also more likely to use Insulin com-
pared to those who were moderately and highly adherent
to their medication (58.7 % vs 37.3 % vs 27.5 % respect-
ively, p < 0.001). Low adherents to medication were also
less likely to have other chronic conditions compared to
those who were moderately and highly adherent to
their medication (46.9 % vs 64.4 % vs 75.0 % respect-
ively, p < 0.001) Table 5.
Low adherents to medication had shorter mean dur-
ation of diabetes compared to those who were moderately
and highly adherent to their medication (Mean 2 years vs
4 years vs 7 years respectively, p < 0.05).
Table 4 Cultural variables in relation to adherence levels
Adherence level
Low adherence
(MMAS-8 < 6)
Medium adherence
(MMAS-8 = 6 to 7)
High adherence
(MMAS-8 = 8)
n Column % n Column % n Column %
What do you mostly wear? Shirt, trousers, shorts, skirt. 70a 24.3 % 95b 80.5 % 17c 42.5 %
Dishdasha/Abaya/Kandoura/Jelbab 218a 75.7 % 23b 19.5 % 23c 57.5 %
Do you alter your medication in Ramadan under
the guidance of your doctor?
Yes 23a 8.0 % 55b 46.6 % 27b 67.5 %
No 265a 92.0 % 63b 53.4 % 13b 32.5 %
Do you notice any changes in your weight? Yes 43a 14.9 % 44b 37.3 % 28c 70.0 %
No 245a 85.1 % 74b 62.7 % 12c 30.0 %
Do you gain or lose weight in Ramadan? Lose weight 40a 13.9 % 44b 37.3 % 20b 50.0 %
Stay the same 7a 2.4 % 17b 14.4 % 7b 17.5 %
Gain weight 241a 83.7 % 57b 48.3 % 13b 32.5 %
Do you see plumpness as a sign of beauty? Yes 150a 52.1 % 52a 44.1 % 15a 37.5 %
No 138a 47.9 % 66a 55.9 % 25a 62.5 %
Do you find hot weather (Summer) a challenge
to exercise?
Yes 254a 88.2 % 47b 39.8 % 19b 47.5 %
No 34a 11.8 % 71b 60.2 % 21b 52.5 %
Note: Values in the same row and sub-table not sharing the same subscript are significantly different at p < .05 in the two-sided test of equality for column proportions.
Cells with no subscript are not included in the test. Tests assume equal variances1
1. Tests are adjusted for all pairwise comparisons within a row of each innermost sub-table using the Bonferroni correction
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Multi-logistic regression analysis
The following points were undertaken during multilogis-
tic regression analysis. Adherence was re-classified into
adherents (MMAS-8 > 6) and non-adherents groups
(MMAS-8 < 6).
Multilogistic regression performed using IBM SPSS
Version 20 with all the variables described above. Cox &
Snell R square = 0.660 and Nagelkerke R Square = 0.908;
indicating good fitness of model.
The strongest predictor for adherence as predicted by
the multi-logistic regression model was the patient’s
level of education. A technical diploma certificate as
compared to a primary school level of education was the
strongest predictor of adherence (OR = 66.1 CI: 6.93 to
630.43); p < 0.001). The patient’s age was also a predictor
of adherence with older patients reporting higher levels
of adherence (OR = 1.113 (CI: 1.045 to 1.185; p = 0.001
for every year increase in age). The duration of diabetes
was also a predictor of adherence (OR = 1.830 (CI: 1.270
to 2.636; p = 0.001 for every year increase in the duration
of diabetes). The patient’s ethnicity was also a predictor
of adherence with Arab Non-Emirati and Asian ethnici-
ties predicting a higher level of adherence compared
with Emirati ethnicity (OR = 8.830 (CI: 2.052 to 37.995)
p = 0.003; OR = 39.4 (CI: 1.819 to 853.46) p = 0.19 re-
spectively). University level of education was a predictor
for adherence compared to primary/secondary school
level of education (OR = 19.6 (CI: 1.872 to 205.130);
p = 0.013). The behaviour of altering one’s medication
under the guidance of their doctor during the fasting
month of Ramadan was a strong predictor of adherence
as well (OR = 62.68 (CI: 9.324 to 421.286; p < 0.001). The
behaviour of patients around paying attention to one’s
weight was a predictor of adherence as well (OR = 7.965
(CI: 1.971 to 32.18; p = 0.004). Conversely, the challenge
of exercising due to hot weather in summer was a
predictor of non-adherence (OR = 0.170 (CI: 0.037 to
0.777) p = 0.022). Similarly insulin use and traditional
Arabic dress code were associated with non-adherence
(OR = 0.188 (CI: 0.05 to 0.709); p = 0.014; OR = 0.010 (CI:
0.002 to 0.071) p = 0.188 respectively) (Table 6, Fig. 2).
Discussion
Limited data exist on the adherence of diabetics in the
United Arab Emirates to their medication prescribed by
their doctors as well as on the factors influencing their
adherence. Studies in other countries have demonstrated
poor adherence rates of medication among diabetics and
patients suffering with other chronic conditions. Al
Mazroui demonstrated a significant reduction in the
levels of HbA1c among diabetics receiving an intensive
educational program over a 12 month period of time
(baseline vs. 12 months; 95 % confidence interval) of
HbA1c8.5 % (8.3, 8.7) vs. 6.9 % (6.7, 7.1) [22]. Reed dem-
onstrated the important role of chronic diabetes clinics
in the UAE at improving diabetes outcomes as measured
by HbA1c levels and blood pressure [23].
Despite this lack of data from the United Arab
Emirates there have been numerous studies from around
the world looking at the impact of medication adherence
on outcome in patients of chronic medical diseases
including diabetes. An American observational study
concluded that high adherence levels to medication
Table 5 Condition and therapy variables against different reported adherence levels
Adherence level
Low adherence (MMAS-8 < 6) Medium adherence (MMAS-8 = 6 to 7) High adherence (MMAS-8 = 8)
n Column % n Column % n Column %
Anti-diabetic therapy Monotherapy 92a 31.9 % 12b 10.2 % 27c 67.5 %
Combination 196a 68.1 % 106b 89.8 % 13c 32.5 %
Insulin use Yes 169a 58.7 % 44b 37.3 % 11b 27.5 %
No 119a 41.3 % 74b 62.7 % 29b 72.5 %
Presence of chronic conditions Yes 135a 46.9 % 76b 64.4 % 30b 75.0 %
No 153a 53.1 % 42b 35.6 % 10b 25.0 %
Note: Values in the same row and sub-table not sharing the same subscript are significantly different at p < .05 in the two-sided test of equality for column proportions
Table 6 Significant predictors to adherence after multi-logistic
regression modelling
p-
value
Odds
ratio
95 % C.I. for OR
Lower Upper
Age .001 1.113 1.045 1.185
Duration of diabetes/years .001 1.830 1.270 2.636
Arab Non-Emarati ethnicity .003 8.830 2.052 37.995
Asian ethnicity .019 39.400 1.819 853.457
Technical diploma .000 66.076 6.925 630.433
University degree .013 19.596 1.872 205.130
Insulin use .014 .188 .050 .709
Traditional dress code .000 .010 .002 .071
Alteration of diabetes Meds under
GP guidance during Ramadan
.000 62.675 9.324 421.286
Attention to weight change .004 7.965 1.971 32.180
No change in weight in Ramadan .050 14.112 .995 200.233
Difficulty to exercise in summer .022 .170 .037 .777
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among diabetics were associated with an overall reduc-
tion in healthcare costs [24]. Another retrospective study
of over 11,000 patients showed that poorly non -adher-
ent diabetics had higher all-cause hospitalization and all-
cause mortality compared to adherent diabetics [9].
Adherence to medication in diabetes is therefore of
utmost importance, and identifying factors that lead to
poorer medication compliance should be identified to
guide healthcare policy.
The adherence rates among diabetics in this group of
type 2 diabetics followed through a primary care setting
were low (64.6 % of patients were considered non-
adherent with a MMAS-8© adherence score < 6). The
predictors of nonadherence to medications were studied
using a multi-logistic regression model and different
socio-economic, demographic and disease related factors
were identified. The strongest predictor for adherence as
predicted by the multi-logistic regression model was the
patient’s level of education. A technical diploma certifi-
cate as compared to a primary school level of education
was the strongest predictor of adherence (OR = 66.1 CI:
6.93 to 630.43); p < 0.001). This finding of lower adher-
ence levels in those with a lower education achievement
should shift focus on this group with greater levels of
care directed to them to ensure the issue of adherence is
addressed.
The patient’s ethnicity was also found to be a predictor
of lower adherence levels, with the local Emirati popula-
tion having a lower level of adherence. Non-Emirati
patients tend to be a highly skilled workforce reflecting a
higher level of education and skills. This could explain
the higher level of understanding of their underlying
medical condition and the importance of medication
adherence.
The patient’s age was also a predictor of adherence
with older patients reporting higher levels of adherence
(OR = 1.113 (CI: 1.045 to 1.185; p = 0.001 for every year
increase in age). The duration of diabetes was also a
predictor of adherence (OR = 1.830 (CI: 1.270 to 2.636;
p = 0.001 for every year increase in the duration of dia-
betes). Subsequently, younger patients with a shorter
duration of diabetes are less likely to have come to terms
with the diagnosis of their diabetes and had a shorter
time to grasp the concept of medication adherence than
their older counterparts. This group of patients tend to
be more vulnerable and therefore require more policies
to be in place to ensure they are well supported and
encouraged during this early phase of diagnosis.
The behaviour of altering one’s medication under the
guidance of their doctor during the fasting month of
Ramadan was a strong predictor of adherence as well
(OR = 62.68 (CI: 9.324 to 421.286; p < 0.001). The behav-
iour of patients around paying attention to one’s weight
was a predictor of adherence as well (OR = 7.965 (CI:
1.971 to 32.18; p = 0.004). Conversely, the challenge of
exercising due to hot weather in summer was a
predictor of non-adherence (OR = 0.170 (CI: 0.037 to
0.777) p = 0.022). Similarly insulin use and traditional
Arabic dress code were associated with non-adherence
(OR = 0.188 (CI: 0.05 to 0.709); p = 0.014; OR = 0.010
(CI: 0.002 to 0.071) p = 0.188 respectively).
Non-adherence may arise as a consequence of the
patient knowingly disregarding their treatment regimen
(active non-adherence), or as a consequence of careless-
ness or forgetfulness, whereby patients occasionally omit
their medication from their daily routine or take that
medication later than required (passive non-adherence).
The limitations of this study include the small size,
which despite meeting the pre-determined study size
sample predicted before starting the study would continue
to be a source of population bias error. The MMAS is a
popular, easy and economical method of data collection,
facilitating the collection of a large amount of data in a
short period of time. Furthermore, the questions are pur-
posely phrased to avoid the ‘yes-saying’ bias as it is known
that patients feel they should provide healthcare providers
Fig. 2 Multi-variate logistic regression of predictors to medication adherence
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with a positive response. However, there are limitations to
this method of data collection; the MMAS does not
account for personal or lifestyle factors (e.g. age, physical
ability, means of transport, known methods of communi-
cation, etc.), and the outcome of these questions can be
biased by patients supplying false information. There was
no direct measurement of adherence to medication
however the MMAS-8 score has been well validated in
measuring medication adherence in diabetes and other
chronic conditions.
Conclusion
Adherence to medication among diabetics continues to
be low. A number of important predictors to medication
adherence in diabetics were identified in this study. Such
predictors could help develop policies for improving
adherence in diabetics.
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